To further examine whether cGAS hyperactivation directly contributes to the delayed tumor progression and increased T cell infiltration observed in Prmt3-KO tumors, we knocked down cGAS in Prmt3-KO Hepa1-6 cells. The gene discussed is PRMT3; the disease is neoplasm.